MK0217

· Organon and Co

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MK0217, covering 2024-08-14 to 2024-08-14. Get the full timeline:

Most recent: Clinical Trial Update: A Research Study to Evaluate the Safety and Effectiveness of MK0217 to Prevent and Treat Bone Loss (0217-193)(COMPLETED) [Phase 3]

See pricing